Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 9 - Medicinal preparations characterised by special physical form
Patents for A61K 9 - Medicinal preparations characterised by special physical form (299,044)
05/2003
05/13/2003US6562368 Transdermal administration of oxybutynin using hydroxide-releasing agents as permeation enhancers
05/13/2003US6562367 Solvent free formulation; minimum thermal exposure; high bioavailability; sustained release
05/13/2003US6562363 Bioadhesive compositions and methods for topical administration of active agents
05/13/2003US6562362 Copolymer of n-isopropylacrylamide and an ionic strength or pH sensitive monomer; nondegradable; side effects reduction
05/13/2003US6562360 Useful as skin disinfectants, surgical hand preparations, patient skin preparations and antimicrobial hand lotions
05/13/2003US6562358 Nontoxic vernix compositions and method of producing
05/13/2003US6562357 Blackhead removing sheet and method for producing blackhead removing sheet
05/13/2003US6562356 Oil in water emulsions
05/13/2003US6562350 Combined vaccine against both HAV and measles virus and method of producing it
05/13/2003US6562336 Dietary or pharmaceutical composition for use for the prevention or treatment of hyperoxaluria
05/13/2003US6562318 Nerve adhesion molecule coupled to active substance; undergoes axonal transport following neuronal endocytosis when contacted with nerve terminus in vascularized innervated tissue
05/13/2003US6562316 Drug delivery system with two-step targeting
05/13/2003US6562075 Prosthetic foot with tunable performance
05/13/2003US6562004 Transdermal delivery
05/13/2003US6562001 Microprocessor controlled ambulatory medical apparatus with hand held communication device
05/13/2003CA2315877C Facilitated oxygen delivery in conjunction with hemodilution
05/13/2003CA2235607C Process for aqueous granulation of clarithromycin
05/13/2003CA2138975C Topical application composition
05/13/2003CA2096575C Novel simethicone containing pharmaceutical compositions
05/09/2003CA2464707A1 Compositions for treatment of postmenopausal female sexual dysfunction
05/08/2003WO2003038103A1 Method for gene transfection using synergistic combinations of cationic lipids and cationic polymers
05/08/2003WO2003037845A1 Compositions for treating acne comprising phytandiol amine
05/08/2003WO2003037607A1 A system and method for uniaxial compression of an article, such as a three-dimensionally printed dosage form
05/08/2003WO2003037412A2 A device, method and resistive element for vaporising a medicament
05/08/2003WO2003037407A1 Transdermal transport device with suction
05/08/2003WO2003037406A2 Transdermal transport device with an electrolytic actuator
05/08/2003WO2003037405A1 Impedance sensor
05/08/2003WO2003037404A1 Microneedle transdermal transport device
05/08/2003WO2003037403A1 Microneedle transport device
05/08/2003WO2003037398A2 Improved stent coating
05/08/2003WO2003037393A1 Plaster having laminated support
05/08/2003WO2003037385A1 Water-soluble polymer conjugates of retinoic acid
05/08/2003WO2003037382A1 Low concentration of peroxide for treating or preventing vaginal infections
05/08/2003WO2003037381A1 Vaginally administerd anti-dysrhythmic agents for treating pelvic pain and infertility
05/08/2003WO2003037380A1 Parenteral chlorambucil for treatment of malignant and autoimmune disease and methods of use
05/08/2003WO2003037379A1 Use of granular materials based on pyrogenically produced silicon dioxide in pharmaceutical compositions
05/08/2003WO2003037374A1 Method of treatment of vulval vestibulitis
05/08/2003WO2003037360A1 Method and composition for repairing and promoting regeneration of mucosal tissue in the gastrointestinal tract
05/08/2003WO2003037350A1 New dry and aqueous epinastine-syrup-formulation
05/08/2003WO2003037348A1 Antagonists of prostaglandin receptors ep2 and/or ep4 for the treatment of dysmenorrhea and menorrhagia
05/08/2003WO2003037342A1 Method of treating depression with delta receptor agonist compounds
05/08/2003WO2003037341A1 Method for the treatment of overactive bladder
05/08/2003WO2003037337A1 Depot formulations of iloperidone and a star polymer
05/08/2003WO2003037320A1 Pharmaco-dietary preparation having a nutrition-supplementing and nutrition-enhancing effect
05/08/2003WO2003037317A1 Albuterol inhalation solution, system, kit and method for relieving symptoms of pediatric asthma
05/08/2003WO2003037314A2 Medical compositions for intravesical treatment of bladder cancer
05/08/2003WO2003037312A2 Ribavirin syrup formulations
05/08/2003WO2003037307A1 Volatilization of a drug from an inclusion complex
05/08/2003WO2003037306A2 Inhalation of vapour of therapeutical substances, like e.g. cannabis extract
05/08/2003WO2003037305A1 Flow regulator
05/08/2003WO2003037304A1 Controlled release compositions for macrolide antimicrobial agents
05/08/2003WO2003037303A1 Spray drying methods and compositions thereof
05/08/2003WO2003037302A1 Method and system for the co-isolation of cognate dna, rna and protein sequences and method for screening co-isolates for defined activities
05/08/2003WO2003037301A2 Oral dosage forms for improving the bioavailability of therapeutic agents
05/08/2003WO2003037300A1 Gastric raft composition
05/08/2003WO2003037299A1 Novel formulation
05/08/2003WO2003037298A2 Bowel cleansing agent
05/08/2003WO2003037297A2 Photosensitizer functionalised nanoparticles
05/08/2003WO2003037296A2 Methods and dosage forms for improving the bioavailability of therapeutic agents
05/08/2003WO2003037295A2 Micelle compositions containing pegylated phospholipids and a photosensitizer
05/08/2003WO2003037291A1 Cream for treatment of skin injured by the sun
05/08/2003WO2003037278A1 Surfactant-containing cosmetic cleaning emulsions
05/08/2003WO2003037276A1 Delivery of hydrogel compositions as a fine mist
05/08/2003WO2003037248A2 Fibrin nanoparticles and uses thereof
05/08/2003WO2003037244A2 System for manufacturing controlled release dosage forms, such as a zero-order release profile dosage form manufactured by three-dimensional printing
05/08/2003WO2003037223A1 Apparatus and methods for variably controlled substance delivery from implanted prostheses
05/08/2003WO2003037159A2 An albuterol and ipratropium inhalation solution, system, kit and method for relieving symptoms of chronic obstructive pulmonary disease
05/08/2003WO2003017929A3 Method for treating bronchial constriction and bronchospasm
05/08/2003WO2003011224A3 Pharmaceutical compositions containing beta-lapachone, or derivatives or analogs thereof, and methods of using same
05/08/2003WO2002102305B1 Adjuvant composition for mucosal and injection delivered vaccines
05/08/2003WO2002102304A3 Gum resin as a carrier for topical application of pharmacologically active agents
05/08/2003WO2002098482A3 System for osmotic delivery of pharmaceutically active agents
05/08/2003WO2002087494A3 Novel vaccine
05/08/2003WO2002085414A3 Nsaid formulations comprising lecithin oils for protecting the gastrointestinal tract and providing enhanced therapeutic activity
05/08/2003WO2002076427A3 Ph sensitive liposomal drug delivery
05/08/2003WO2002053089B1 Stable skin conditioning compositions containing retinoid boosters
05/08/2003WO2002036110A3 Oral self-emulsifying formulations of pyranone protease inhibitors
05/08/2003WO2002009702A8 Use of indole derivatives for the manufacture of a medicament for reducing intracular pressure
05/08/2003WO2001082899A9 Cationic diagnostic, imaging and therapeutic agents associated with activated vascular sites
05/08/2003US20030088307 Potent coatings for stents
05/08/2003US20030088238 Modular drug delivery system
05/08/2003US20030088237 Treatment protocol generation for diseases related to angiogenesis
05/08/2003US20030088236 Implantable devices and methods for treatment of pain by delivery of fentanyl and fentanyl congeners
05/08/2003US20030088233 For use in ocular surgery; containing a vital dyes, especially a disazo dye, that does not diffuse out of the visco-elastic composition.
05/08/2003US20030088199 Analgesic and anti-inflammatory patches for external use containing 4-biphenylylylacetic acid
05/08/2003US20030088176 Non-invasive methods for surgery in the vasculature
05/08/2003US20030087985 Gels for encapsulation of biological materials
05/08/2003US20030087967 Translucent nanoemulsion, production method, and uses thereof in the cosmetic, dermatological and/or opthalmological fields
05/08/2003US20030087954 Method of treating bladder carcinoma using a Taxane/Tocopherol formulation
05/08/2003US20030087953 Method for treating colorectal carcinoma using a taxane/tocopherol formulation
05/08/2003US20030087951 Has cytotoxicity in 7 human tumor cell lines
05/08/2003US20030087947 Novel photosensitizers of 9-hydroxypheophorbide-a derivatives used for photodynamic therapy
05/08/2003US20030087913 Solid pharmaceutical agent formulation for a piperazine urea derivative
05/08/2003US20030087910 E.g., O-(2-quinolinylmethyl)-N-quinaldoyl-D,L-tyrosine
05/08/2003US20030087893 Compositions containing alpha-2-adrenergic agonist components
05/08/2003US20030087885 Treating sexual disorders
05/08/2003US20030087875 Hypersulfated disaccharides and methods of using the same for the treatment of inflammations
05/08/2003US20030087851 Pharmaceutical composition for treating or preventing influenza, and novel oligonucleotide
05/08/2003US20030087844 Ribavirin syrup formulations
05/08/2003US20030087837 Compositions and methods for delivery of poorly water soluble drugs and methods of treatment
1 ... 2143 2144 2145 2146 2147 2148 2149 2150 2151 2152 2153 2154 2155 2156 2157 2158 2159 2160 2161 2162 2163 ... 2991